Company
Cambridge Cognition Holdings PLC
LON:COG
Cambridge Cognition is a brain health software group specialising in digital health products that advance brain health research and treatment. Built on rich, curated data and deep technical expertise, the company is building a strong global brand with scalable technology that will support the rising world demand for diagnosing and treating brain health. It creates shareholder value through organic sales growth, strategic partnerships, joint ventures, and spinouts.
79 stories · page 1 of 4
Archive
Small Cap Feast - Cambridge Cognition Holdings, Cornerstone Fs, Deltic Energy, and more...
11 January 2023*A corporate client of Hybridan LLP** Arranged by most recent first*** Alphabetically arrangedDish of the dayJoiners:No joiners today.Leavers:No leavers today.What’s cooking in the IPO kitchen?**Celsius Resources intends to j
Cambridge Cognition inks £1.1mln deal to provide electronic clinical outcome assessments for rare blood disease trial
“We are pleased to see this new order from an existing client, our reputation for quality, service and scientific rigour is enabling us to win eCOA-only clinical trials," said the company's CEO Matthew Stork
Cambridge Cognition strengthens virtual clinical trials offering with £1.7mln acquisition
eClinicalHealth provided the digital technology for three of the world's 10 largest pharmaceutical companies under its Clinpal brand